Jointown subsidiary's Aoyuan Meigu reorganization accepted by court

On November 14, 2025, Jointown Pharmaceutical Group Co., Ltd. announced its wholly-owned subsidiary, Hubei Jiuzhou Industrial Park Operation and Management Co., Ltd. (Jiuzhou Property Investment Company), is involved in the reorganization of Aoyuan Meigu Technology Co., Ltd. The Xiangyang Intermediate People's Court formally accepted Aoyuan Meigu's reorganization application and appointed Aoyuan Meigu Technology Co., Ltd. Liquidation Group as the administrator.

The initial reorganization investment agreement, signed on April 23, 2025, involved Jiuzhou Property Investment Company contributing 673,200,000 yuan to acquire 360,000,000 newly issued shares of Aoyuan Meigu. A subsequent supplementary agreement on September 24, 2025, adjusted the investment, with Jiuzhou Property Investment Company now acquiring 435,930,312 shares for a total of 706,207,105.44 yuan.

While the court has accepted the reorganization, the successful implementation of the investment and its integration effects remain uncertain, posing risks to investors. Jointown Pharmaceutical Group stated that the investment aligns with its long-term strategic plans and is expected to enhance its core competitiveness and expand into the health and beauty industry.